TY - JOUR
T1 - Malachite green mediates homodimerization of antibody VL domains to form a fluorescent ternary complex with singular symmetric interfaces
AU - Szent-Gyorgyi, Chris
AU - Stanfield, Robyn L.
AU - Andreko, Susan
AU - Dempsey, Alison
AU - Ahmed, Mushtaq
AU - Capek, Sarah
AU - Waggoner, Alan S.
AU - Wilson, Ian A.
AU - Bruchez, Marcel P.
N1 - Funding Information:
We thank Brigitte Schmidt for MG-QSY21 dye conjugation, Yehuda Creeger for flow cytometry, and Carol Woolford and Peter Berget for help in affinity maturation. This work was supported by a grant from the National Institutes of Health (8U54GM103529-08).
PY - 2013/11/15
Y1 - 2013/11/15
N2 - We report that a symmetric small-molecule ligand mediates the assembly of antibody light chain variable domains (VLs) into a correspondent symmetric ternary complex with novel interfaces. The L5* fluorogen activating protein is a VL domain that binds malachite green (MG) dye to activate intense fluorescence. Crystallography of liganded L5* reveals a 2:1 protein:ligand complex with inclusive C2 symmetry, where MG is almost entirely encapsulated between an antiparallel arrangement of the two V L domains. Unliganded L5* VL domains crystallize as a similar antiparallel VL/VL homodimer. The complementarity-determining regions are spatially oriented to form novel V L/VL and VL/ligand interfaces that tightly constrain a propeller conformer of MG. Binding equilibrium analysis suggests highly cooperative assembly to form a very stable VL/MG/VL complex, such that MG behaves as a strong chemical inducer of dimerization. Fusion of two VL domains into a single protein tightens MG binding over 1000-fold to low picomolar affinity without altering the large binding enthalpy, suggesting that bonding interactions with ligand and restriction of domain movements make independent contributions to binding. Fluorescence activation of a symmetrical fluorogen provides a selection mechanism for the isolation and directed evolution of ternary complexes where unnatural symmetric binding interfaces are favored over canonical antibody interfaces. As exemplified by L5*, these self-reporting complexes may be useful as modulators of protein association or as high-affinity protein tags and capture reagents.
AB - We report that a symmetric small-molecule ligand mediates the assembly of antibody light chain variable domains (VLs) into a correspondent symmetric ternary complex with novel interfaces. The L5* fluorogen activating protein is a VL domain that binds malachite green (MG) dye to activate intense fluorescence. Crystallography of liganded L5* reveals a 2:1 protein:ligand complex with inclusive C2 symmetry, where MG is almost entirely encapsulated between an antiparallel arrangement of the two V L domains. Unliganded L5* VL domains crystallize as a similar antiparallel VL/VL homodimer. The complementarity-determining regions are spatially oriented to form novel V L/VL and VL/ligand interfaces that tightly constrain a propeller conformer of MG. Binding equilibrium analysis suggests highly cooperative assembly to form a very stable VL/MG/VL complex, such that MG behaves as a strong chemical inducer of dimerization. Fusion of two VL domains into a single protein tightens MG binding over 1000-fold to low picomolar affinity without altering the large binding enthalpy, suggesting that bonding interactions with ligand and restriction of domain movements make independent contributions to binding. Fluorescence activation of a symmetrical fluorogen provides a selection mechanism for the isolation and directed evolution of ternary complexes where unnatural symmetric binding interfaces are favored over canonical antibody interfaces. As exemplified by L5*, these self-reporting complexes may be useful as modulators of protein association or as high-affinity protein tags and capture reagents.
KW - cooperative binding
KW - directed evolution
KW - fluorogen activating protein
KW - quaternary structure
KW - yeast surface display
UR - http://www.scopus.com/inward/record.url?scp=84886718229&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2013.08.014
DO - 10.1016/j.jmb.2013.08.014
M3 - Article
C2 - 23978698
AN - SCOPUS:84886718229
SN - 0022-2836
VL - 425
SP - 4595
EP - 4613
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 22
ER -